GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (OTCPK:CNTMF) » Definitions » Other Financing

CNTMF (Cansortium) Other Financing : $-0.8 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium Other Financing?

Cansortium's Other Financing for the three months ended in Sep. 2024 was $0.0 Mil.

Cansortium's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.8 Mil.


Cansortium Other Financing Historical Data

The historical data trend for Cansortium's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Other Financing Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial 0.20 1.18 10.38 0.30 -

Cansortium Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 -0.80 - - -

Cansortium Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cansortium Other Financing Related Terms

Thank you for viewing the detailed overview of Cansortium's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Cansortium Business Description

Traded in Other Exchanges
Address
82 North East 26th Street, Unit 110, Miami, FL, USA, 33137
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

From GuruFocus

Cansortium Reports Third Quarter 2024 Results

By PRNewswire 11-29-2024

Q2 2023 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2024 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 08-23-2024

Q3 2020 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024